PhageLab

PhageLab is a Chilean biotech company developing bacteriophage-based solutions as a precise and natural alternative to antibiotics in animal production. Founded in 2010, the company combines artificial intelligence with deep epidemiological diagnostics through its proprietary LEIDEN® platform to design tailored treatments against pathogens such as Salmonella and E. coli in the poultry and livestock industries.

With operations and commercial presence in Brazil, Spain, and Asia, and backing from leading investors such as Kaszek, PhageLab is building a globally scalable approach to one of the most pressing challenges in animal health and food systems: antimicrobial resistance.

At the Global Innovation Summit, PhageLab is looking to connect with investors, R&D partners, technology centres, specialised laboratories, manufacturers, and innovation collaborators interested in scaling next-generation biotech solutions for animal health. The company is particularly interested in partnerships that can support international collaborative R&D, outsourced technical activities, product development, validation, formulation, advanced biological manufacturing, and access to new markets.

PhageLab can contribute strong capabilities in biological product manufacturing, molecular biology and NGS laboratories, drug discovery, formulation, and experience in fundraising and international growth. The company is open to exploring joint R&D and innovation projects with partners that share an interest in biotechnology, health-related innovation, sustainable food production, and scalable international deployment.